Mifepristone and Misoprostol for 2nd Trimester Termination of Pregnancy in Burkina Faso

Mifepristone and Misoprostol for 2nd Trimester Termination of Pregnancy (13-22 Weeks LMP) in Burkina Faso

The goal of this study is to examine the effectiveness and feasibility of a mifepristone-misoprostol medical abortion regimen in terminating pregnancies 13-22 weeks in Burkina Faso.

Inclusion Criteria:

• Having an ongoing pregnancy of 13-22 weeks gestation
• Be willing to undergo surgical completion if necessary
• Have no contraindications to study procedures, according to provider
• Be willing and able to consent to participate in the study
• Be willing to follow study procedures
• Respect legal indications for obtaining an abortion

Exclusion Criteria:

• Known allergy to mifepristone or misoprostol/prostaglandin
• Any contraindications to vaginal delivery, including placenta previa
• Previous transmural uterine incsion